Contact and place of performance
ST JOHN, ADELOLA O
Not specified
The objective of this contract is for a Chemical Screening and Optimization Facility (CSOF) with the capability to carry out the production of active recombinant protein, assay development, chemical screening, identification and optimization of chemical lead series and production of milligram to kilogram quantities of materials for in vitro and in vivo testing for contraception and/or reproductive health-related therapeutic indications.
The objective of solicitation 75N94023R00008 is to establish a Chemical Screening and Optimization Facility (CSOF) capable of supporting contraception and reproductive health-related therapeutic indications. The facility will be responsible for the production of active recombinant protein, assay development, chemical screening, and the identification and optimization of chemical lead series. Performance involves producing milligram to kilogram quantities of materials intended for both in vitro and in vivo testing.
This requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH. Adelola O. St John is the designated point of contact for this project.
The response deadline for this solicitation is June 8, 2023. The notice was originally published on March 31, 2023, with the most recent update occurring on May 31, 2023. Documentation for this opportunity includes two files posted on April 21, 2023, titled Sol_75N94023R00008.pdf and Chemical_Optimization_Screening_Facility_RFP.pdf.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.